Mangoceuticals, Inc. (MGRX)

Mangoceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022
Period Ending	Mar 13, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Market Cap	6	8	6	-
Market Cap Growth	-71.12%	32.54%	-	-
Enterprise Value	5.89	7.94	5.25	0
Last Close Price	0.38	2.42	4.15	-
PE Ratio	-	-0.50	-0.48	-
PS Ratio	13.40	12.75	8.10	-
PB Ratio	0.34	0.58	7.65	-
P/TBV Ratio	0.18	0.35	5.75	-
P/FCF Ratio	-	-1.61	-0.85	-
P/OCF Ratio	-	-1.61	-0.85	-
EV/Sales Ratio	12.61	12.90	7.18	-
EV/EBITDA Ratio	-	-1.00	-0.57	-
EV/EBIT Ratio	-	-0.91	-0.57	-
EV/FCF Ratio	-	-1.63	-0.75	-
Debt / Equity Ratio	0.00	0.01	0.04	0.48
Debt / EBITDA Ratio	-0.01	-0.03	-0.01	-0.18
Debt / FCF Ratio	-0.02	-0.04	-0.02	-0.25
Net Debt / Equity Ratio	-0.02	0.01	-0.79	-0.54
Net Debt / EBITDA Ratio	0.02	-0.02	0.07	0.17
Net Debt / FCF Ratio	0.06	-0.03	0.09	0.24
Asset Turnover	0.03	0.08	0.71	0.01
Inventory Turnover	-	25.50	32.43	-
Quick Ratio	0.60	0.04	3.50	2.62
Current Ratio	0.74	0.05	3.96	2.67
Return on Equity (ROE)	-66.80%	-59.15%	-851.61%	-325.40%
Return on Assets (ROA)	-121.56%	-105.88%	-897.62%	-198.51%
Return on Invested Capital (ROIC)	-129.29%	-118.77%	-4111.34%	-701.17%
Return on Capital Employed (ROCE)	-130.69%	-117.60%	-1165.16%	-268.15%
Earnings Yield	-332.04%	-200.00%	-206.75%	-
FCF Yield	-94.33%	-61.92%	-118.14%	-
Buyback Yield / Dilution	-15.70%	-16.91%	-121.91%	-

Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q